HERCESSI
- Product NDC
- 69448-035
- Requested package NDC
- 69448-035-63
- 11-digit product format
- 694480035
- Labeler code
- 69448
- Product ID
- 69448-035_893932c5-c667-4ed0-a2bd-a62cc5800b14
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Trastuzumab-strf
- Dosage form
- KIT
- Labeler
- Accord BioPharma Inc.
- Application
- BLA761346
- Marketing category
- BLA
- Marketing start
- 2026-10-01
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HERCESSI
- Listing expiration
- 2027-12-31
Harmonized UNII identifiers#
UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| P188ANX8CK | Internal UNII lookup |
Harmonized RxCUI identifiers#
RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 2700718 | Internal RxNorm lookup |
| 2700724 | Internal RxNorm lookup |
| 2700727 | Internal RxNorm lookup |
| 2700731 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts#
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761346 | Hercessi | trastuzumab-strf | 351(k) Biosimilar | Rx | 2026-10-01 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69448-035-63 | 69448003563 | 1 KIT in 1 CARTON (69448-035-63) * 20 mL in 1 VIAL, MULTI-DOSE (69448-016-11) * 20 mL in 1 VIAL (69448-034-05) | 1 kit | 2026-10-01 | No | No | Current |